您的位置: 首页 > 农业专利 > 详情页

COMBINATION THERAPY CONTAINING A PI3K-ALPHA INHIBITOR AND FGFR KINASE INHIBITOR FOR TREATING CANCER
专利权人:
Christine FRITSCH
发明人:
Christine Fritsch,Christian Chatenay-Rivauday,Johannes Roesel,Markus Wartmann,Diana Graus Porta
申请号:
US14892082
公开号:
US20160095842A1
申请日:
2014.05.28
申请国别(地区):
US
年份:
2016
代理人:
摘要:
A pharmaceutical combination comprising an alpha-isoform specific phosphatidylinositol 3-kinase inhibitor compound of formula (I) or a pharmaceutically acceptable salt thereof and a fibroblast growth factor receptor (FGFR) kinase inhibitor, particularly for simultaneous, separate or sequential use for the treatment of a cancer use of such pharmaceutical combination for the preparation of a medicament for the treatment of a cancer use of such pharmaceutical combination for the treatment a cancer a method for treating a cancer comprising administering to a subject having said cancer a jointly therapeutically effective amount of such combination and related pharmaceutical compositions or kits thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充